★★★★☆
4.2 étoiles sur 5 de 483 avis
1999-07-23
Novel Therapeutics from Modern Biotechnology - de Dale L.Oxender (Author)
Details Novel Therapeutics from Modern Biotechnology
Le paragraphe suivant répertorie des caractéristiques utiles du Novel Therapeutics from Modern Biotechnology
| Le Titre Du Livre | Novel Therapeutics from Modern Biotechnology |
| Date de Parution | 1999-07-23 |
| Traducteur | Jorgie Joven |
| Quantité de Pages | 637 Pages |
| Taille du fichier | 52.97 MB |
| Langue | Anglais & Français |
| Éditeur | Open University Press |
| ISBN-10 | 8822645732-HYJ |
| Type de Document | AMZ PDF EPub MCW SXW |
| Écrivain | Dale L.Oxender |
| ISBN-13 | 526-7352751949-DLV |
| Nom de Fichier | Novel-Therapeutics-from-Modern-Biotechnology.pdf |
Télécharger Novel Therapeutics from Modern Biotechnology Livre PDF Gratuit
aTen Therapeutics An innovative biotechnology company We are developing novel therapeutic antibody approaches to target a fundamental control pathway associated with several major diseases
NeuroBio is a biotechnology company developing novel therapeutics for neurodegenerative disorders such as Alzheimer’s The basis of the research is a pivotal signalling molecule a 14mer peptide derived from the Cterminus of acetylcholinesterase
Mon compte Gérer votre compte Magazine subscription Receive every issue of Researcheu magazine
À propos Pivot Pharmaceuticals is an emerging biotechnology company engaged in the development of novel therapeutics to treat unmet medical needs to improve women’s health
FierceBiotech Names Repare Therapeutics as One of Its “Fierce 15” Biotech Companies of 2017 September 26 2017 MONTREAL… Read more Repare Therapeutics Raises US68 Million Series A Communiqué de Presse Par admin août 1 2017 Repare Therapeutics Raises US68 Million Series A Novel cancer company founded by Versant Ventures June 22 2017… Read more Nouvelles Nature Biotechnology
Cambridge December 15 2014—Acceleron Pharma Inc NASDAQ XLRN a biopharmaceutical company focused on the discovery development and commercialization of novel protein therapeutics for cancer and rare diseases today announced it has been selected for addition to the NASDAQ Biotechnology Index
Idera Pharmaceuticals Inc est une société biopharmaceutique spécialisée dans la découverte le développement et la commercialisation de produits thérapeutiques pour loncologie et les